| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| SHL.DE - Siemens Healthineers AG | BUY | 22,633 @ EUR 46.58 | EUR 1,054,245 | The ETF bought 22633 new shares of SHL.DE (Siemens Healthineers AG). The shares were bought for an average price of 46.58 compared to the previous average buy price of 50.3918. This is -7.6% lower than average price of previous purchases of SHL.DE. |
| ROG.SW - | BUY | 2,267 @ CHF 284.668 | CHF 645,342 | The ETF bought 2267 new shares of ROG.SW (). The shares were bought for an average price of 284.668 compared to the previous average buy price of 286.277. This is -0.6% lower than average price of previous purchases of ROG.SW. |
| AZN.L - AstraZeneca PLC | BUY | 4,978 @ GBP 127.342 | GBP 633,908 | The ETF bought 4978 new shares of AZN.L (AstraZeneca PLC). The shares were bought for an average price of 127.342 compared to the previous average buy price of 128.645. This is -1.0% lower than average price of previous purchases of AZN.L. |
| GALD.SW - | BUY | 4,733 @ CHF 115.476 | CHF 546,548 | The ETF bought 4733 new shares of GALD.SW (). The shares were bought for an average price of 115.476 compared to the previous average buy price of 97.4314. This is 18.5% higher than average price of previous purchases of GALD.SW. |
| FME.DE - Fresenius Medical Care AG | BUY | 5,802 @ EUR 50.02 | EUR 290,216 | The ETF bought 5802 new shares of FME.DE (Fresenius Medical Care AG). The shares were bought for an average price of 50.02 compared to the previous average buy price of 45.1945. This is 10.7% higher than average price of previous purchases of FME.DE. |
| EL.PA - EssilorLuxottica SA | BUY | 1,005 @ EUR 244.7 | EUR 245,924 | The ETF bought 1005 new shares of EL.PA (EssilorLuxottica SA). The shares were bought for an average price of 244.7 compared to the previous average buy price of 249.611. This is -2.0% lower than average price of previous purchases of EL.PA. |
| ARGX.BR - Argenx SE | BUY | 402 @ EUR 506.4 | EUR 203,573 | The ETF bought 402 new shares of ARGX.BR (Argenx SE). The shares were bought for an average price of 506.4 compared to the previous average buy price of 561.881. This is -9.9% lower than average price of previous purchases of ARGX.BR. |
| LONN.SW - | BUY | 255 @ CHF 610.294 | CHF 155,625 | The ETF bought 255 new shares of LONN.SW (). The shares were bought for an average price of 610.294 compared to the previous average buy price of 581.134. This is 5.0% higher than average price of previous purchases of LONN.SW. |
| ALC.SW - | BUY | 1,545 @ CHF 75.8043 | CHF 117,118 | The ETF bought 1545 new shares of ALC.SW (). The shares were bought for an average price of 75.8043 compared to the previous average buy price of 82.5763. This is -8.2% lower than average price of previous purchases of ALC.SW. |
| HLN.L - Haleon PLC | BUY | 17,723 @ GBP 4.91667 | GBP 87,138 | The ETF bought 17723 new shares of HLN.L (Haleon PLC). The shares were bought for an average price of 4.91667 compared to the previous average buy price of 4.68648. This is 4.9% higher than average price of previous purchases of HLN.L. |
| BAYN.DE - Bayer AG | BUY | 3,124 @ EUR 24.735 | EUR 77,272 | The ETF bought 3124 new shares of BAYN.DE (Bayer AG). The shares were bought for an average price of 24.735 compared to the previous average buy price of 21.4418. This is 15.4% higher than average price of previous purchases of BAYN.DE. |
| SOON.SW - | BUY | 277 @ CHF 276.198 | CHF 76,507 | The ETF bought 277 new shares of SOON.SW (). The shares were bought for an average price of 276.198 compared to the previous average buy price of 296.607. This is -6.9% lower than average price of previous purchases of SOON.SW. |
| UCB.BR - UCB SA | BUY | 414 @ EUR 159.9 | EUR 66,199 | The ETF bought 414 new shares of UCB.BR (UCB SA). The shares were bought for an average price of 159.9 compared to the previous average buy price of 173.808. This is -8.0% lower than average price of previous purchases of UCB.BR. |
| SDZ.SW - | BUY | 1,287 @ CHF 44.7428 | CHF 57,584 | The ETF bought 1287 new shares of SDZ.SW (). The shares were bought for an average price of 44.7428 compared to the previous average buy price of 39.6366. This is 12.9% higher than average price of previous purchases of SDZ.SW. |
| FRE.DE - Fresenius SE & Co KGaA | BUY | 1,319 @ EUR 43.18 | EUR 56,954 | The ETF bought 1319 new shares of FRE.DE (Fresenius SE & Co KGaA). The shares were bought for an average price of 43.18 compared to the previous average buy price of 36.9698. This is 16.8% higher than average price of previous purchases of FRE.DE. |
| MRK.DE - Merck KGaA | BUY | 370 @ EUR 115.5 | EUR 42,735 | The ETF bought 370 new shares of MRK.DE (Merck KGaA). The shares were bought for an average price of 115.5 compared to the previous average buy price of 132.952. This is -13.1% lower than average price of previous purchases of MRK.DE. |
| RO.SW - | BUY | 122 @ CHF 300.215 | CHF 36,626 | The ETF bought 122 new shares of RO.SW (). The shares were bought for an average price of 300.215 compared to the previous average buy price of 302.837. This is -0.9% lower than average price of previous purchases of RO.SW. |
| GSK.L - GlaxoSmithKline PLC | BUY | 2,018 @ GBP 17.9015 | GBP 36,125 | The ETF bought 2018 new shares of GSK.L (GlaxoSmithKline PLC). The shares were bought for an average price of 17.9015 compared to the previous average buy price of 16.6578. This is 7.5% higher than average price of previous purchases of GSK.L. |
| STMN.SW - | BUY | 314 @ CHF 113.17 | CHF 35,535 | The ETF bought 314 new shares of STMN.SW (). The shares were bought for an average price of 113.17 compared to the previous average buy price of 119.361. This is -5.2% lower than average price of previous purchases of STMN.SW. |
| QIA.DE - QIAGEN NV | BUY | 756 @ EUR 39.75 | EUR 30,051 | The ETF bought 756 new shares of QIA.DE (QIAGEN NV). The shares were bought for an average price of 39.75 compared to the previous average buy price of 36.9082. This is 7.7% higher than average price of previous purchases of QIA.DE. |
| HIK.L - | BUY | 1,150 @ GBP 25.4208 | GBP 29,234 | The ETF bought 1150 new shares of HIK.L (). The shares were bought for an average price of 25.4208 compared to the previous average buy price of 24.2938. This is 4.6% higher than average price of previous purchases of HIK.L. |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | BUY | 551 @ EUR 52.8 | EUR 29,093 | The ETF bought 551 new shares of REC.MI (Recordati Industria Chimica e Farmaceutica SpA). The shares were bought for an average price of 52.8 compared to the previous average buy price of 52.4787. This is 0.6% higher than average price of previous purchases of REC.MI. |
| IPN.PA - Ipsen SA | BUY | 277 @ EUR 103.7 | EUR 28,725 | The ETF bought 277 new shares of IPN.PA (Ipsen SA). The shares were bought for an average price of 103.7 compared to the previous average buy price of 107.743. This is -3.8% lower than average price of previous purchases of IPN.PA. |
| SN.L - Smith & Nephew PLC | BUY | 2,246 @ GBP 12.7639 | GBP 28,668 | The ETF bought 2246 new shares of SN.L (Smith & Nephew PLC). The shares were bought for an average price of 12.7639 compared to the previous average buy price of 12.7565. This is 0.1% higher than average price of previous purchases of SN.L. |
| DIM.PA - Sartorius Stedim Biotech | BUY | 147 @ EUR 194 | EUR 28,518 | The ETF bought 147 new shares of DIM.PA (Sartorius Stedim Biotech). The shares were bought for an average price of 194 compared to the previous average buy price of 190.027. This is 2.1% higher than average price of previous purchases of DIM.PA. |
| SOBI.ST - | BUY | 1,044 @ SEK 26.8892 | SEK 28,072 | The ETF bought 1044 new shares of SOBI.ST (). The shares were bought for an average price of 26.8892 compared to the previous average buy price of 26.8963. This is 0.0% lower than average price of previous purchases of SOBI.ST. |
| SRT3.DE - Sartorius AG | BUY | 129 @ EUR 211 | EUR 27,219 | The ETF bought 129 new shares of SRT3.DE (Sartorius AG). The shares were bought for an average price of 211 compared to the previous average buy price of 223.287. This is -5.5% lower than average price of previous purchases of SRT3.DE. |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 59.75 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 59.75. The average price that ORNBV.HE shares were previous bought at was EUR 49.2948. The current market price is 21.2% higher than average price they were purchased at. The value of the holding in ORNBV.HE has increased by EUR 75,159 (USD $85,519) compared to the previous valuation of Orion Oyj however if the holding was sold on 2025-05-30 this would crystalise an overall loss. |
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 118.1 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 118.1. The average price that BIM.PA shares were previous bought at was EUR 109.561. The current market price is 7.8% higher than average price they were purchased at. The value of the holding in BIM.PA has increased by EUR 17,659 (USD $20,093) compared to the previous valuation of BioMerieux however if the holding was sold on 2025-05-30 this would crystalise an overall loss. |
| GMAB.CO - | HOLD | 0 @ DKK 184.933 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 184.933. The average price that GMAB.CO shares were previous bought at was DKK 190.727. The current market price is -3.0% lower than average price they were purchased at. The value of the holding in GMAB.CO has fallen by DKK 110 (USD $17) compared to the previous valuation of |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ EUR 20.25 | EUR 0 | The current share valuation price of PHIA.AS based on adjusted close was EUR 20.25. The average price that PHIA.AS shares were previous bought at was EUR 23.6773. The current market price is -14.5% lower than average price they were purchased at. The value of the holding in PHIA.AS has fallen by EUR 9,172 (USD $10,436) compared to the previous valuation of Koninklijke Philips NV |
| DEMANT.CO - | HOLD | 0 @ DKK 34.453 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 34.453. The average price that DEMANT.CO shares were previous bought at was DKK 34.2927. The current market price is 0.5% higher than average price they were purchased at. The value of the holding in DEMANT.CO has fallen by DKK 28 (USD $4) compared to the previous valuation of |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 9.47 | EUR 0 | |
| DIA.MI - DiaSorin SpA | HOLD | 0 @ EUR 91.36 | EUR 0 | The current share valuation price of DIA.MI based on adjusted close was EUR 91.36. The average price that DIA.MI shares were previous bought at was EUR 66.4761. The current market price is 37.4% higher than average price they were purchased at. The value of the holding in DIA.MI has increased by EUR 1,574 (USD $1,791) compared to the previous valuation of DiaSorin SpA however if the holding was sold on 2025-05-30 this would crystalise an overall loss. |
| NOVO-B.CO - Novo Nordisk A/S | HOLD | 0 @ DKK 60.8155 | DKK 0 | The current share valuation price of NOVO-B.CO based on adjusted close was DKK 60.8155. The average price that NOVO-B.CO shares were previous bought at was DKK 66.7595. The current market price is -8.9% lower than average price they were purchased at. The value of the holding in NOVO-B.CO has fallen by DKK 1,814 (USD $277) compared to the previous valuation of Novo Nordisk A/S |
| COLO-B.CO - | HOLD | 0 @ DKK 85.2074 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 85.2074. The average price that COLO-B.CO shares were previous bought at was DKK 94.804. The current market price is -10.1% lower than average price they were purchased at. The value of the holding in COLO-B.CO has fallen by DKK 100 (USD $15) compared to the previous valuation of |
| ERF.PA - Eurofins Scientific SE | SELL | -6,250 @ EUR 58.74 | EUR -367,125 | The ETF sold 6250 shares of ERF.PA on 2025-05-30. The shares were previously bought for an average price of EUR 50.2178. The Eurofins Scientific SE shares were sold for 17.0% higher than average price of previous purchases. This sale made a profit of EUR 53,264 (USD $60,605) The average price that the ETF previously sold ERF.PA share for is EUR 51.1136 so the ETF has sold 6250 shares on 2025-05-30 at a higher price than the previous selling average. |
| SAN.PA - Sanofi SA | SELL | -6,668 @ EUR 87.52 | EUR -583,583 | The ETF sold 6668 shares of SAN.PA on 2025-05-30. The shares were previously bought for an average price of EUR 96.5074. The Sanofi SA shares were sold for -9.3% lower than average price of previous purchases. This resulted in an overall loss of EUR 59,928 (USD $68,188) The average price that the ETF previously sold SAN.PA share for is EUR 93.5469 which is higher than the selling price of EUR 87.52 on 2025-05-30. |
| NOVN.SW - | SELL | -20,669 @ CHF 100.819 | CHF -2,083,828 | The ETF sold 20669 shares of NOVN.SW on 2025-05-30. The shares were previously bought for an average price of CHF 97.6741. The shares were sold for 3.2% higher than average price of previous purchases. This sale made a profit of CHF 65,002 (USD $79,072) The average price that the ETF previously sold NOVN.SW share for is CHF 98.5778 so the ETF has sold 20669 shares on 2025-05-30 at a higher price than the previous selling average. |